[Teriparatide as a therapy approach in sacral insufficiency fractures]

G Hohenberger; A Schwarz; E Hartwig; B Bücking

doi:10.1007/s00113-017-0400-8

[Teriparatide as a therapy approach in sacral insufficiency fractures]

Unfallchirurg. 2017 Nov;120(11):1000-1003. doi: 10.1007/s00113-017-0400-8.

[Article in German]

Authors

G Hohenberger¹, A Schwarz², E Hartwig³, B Bücking⁴

Affiliations

¹ Universitätsklinik für Orthopädie und Traumatologie Graz, Auenbruggerplatz 5, 8036, Graz, Österreich. gloria.hohenberger@medunigraz.at.
² AUVA Unfallkrankenhaus Graz, Graz, Österreich.
³ Abteilung für Orthopädie und Unfallchirurgie, Diakonissenkrankenhaus, Karlsruhe-Rüppurr, Deutschland.
⁴ Zentrum für Orthopädie und Unfallchirurgie, Universitätsklinikum Marburg, Marburg, Deutschland.

PMID: 28819813
DOI: 10.1007/s00113-017-0400-8

Abstract

As a result of immense heterogeneity with regard to morphology and stability, the recent literature lacks consensus concerning the treatment of sacral insufficiency fractures. We report the case of a 79-year-old woman with bilateral sacral insufficiency fractures following anterior pelvic ring fractures who was treated with teriparatide. During a two-week hospital stay, the patient was successfully mobilised and the regularly conducted pelvic X‑ray controls showed full consolidation of the fractures.

Keywords: Forsteo®; Insufficiency fracture; Parathyroid hormone; Sacral insufficiency fracture; Teriparatide.

MeSH terms

Aged
Bone Density Conservation Agents* / therapeutic use
Female
Fractures, Stress* / drug therapy
Humans
Pelvic Bones*
Sacrum
Spinal Fractures* / drug therapy
Teriparatide* / therapeutic use

Substances

Bone Density Conservation Agents
Teriparatide